Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nicholas Anast

Anesthesiology Reno, NV Medical Doctor

NPI 1477877173 CMS profile 433959

235 W 6Th St, Reno, NV 89503

Open in the dashboard

General payments

$28,434

122 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicholas Anast of Reno, NV is reported in the CMS Open Payments database as having received $28,434 across 122 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,417 44
2024 General $773 30
2023 General $4,265 14
2022 General $21,080 11
2021 General $495 14
2020 General $142 7
2019 General $262 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Anast
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Nicholas Anast were reported at $1,417. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Nicholas Anast Anesthesiology median Middle half National median
2019 $262 $72 $23–$151 $163
2020 $142 $36 $17–$120 $114
2021 $495 $49 $21–$135 $132
2022 $21,080 $52 $22–$144 $149
2023 $4,265 $53 $23–$143 $160
2024 $773 $55 $25–$150 $164
2025 $1,417 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $26,321 38 payments
  2. Boston Scientific Corporation $934 31 payments
  3. Biosense Webster, Inc. $628 31 payments
  4. Medtronic, Inc. $201 10 payments
  5. Abbott Laboratories $137 6 payments
  6. Silk Road Medical, Inc. $120 1 payment
  7. Abiomed $23 1 payment
  8. AngioDynamics, Inc. $22 1 payment
  9. Merck Sharp & Dohme Corporation $17 1 payment
  10. Maquet Cardiovascular U.S. Sales, L.L.C. $17 1 payment
  11. Other $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $21,175 6 payments
  2. Travel and Lodging $3,682 2 payments
  3. Food and Beverage $3,577 114 payments
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $25,002 9 payments
  2. Carto 3 $590 30 payments
  3. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Transcatheter Heart Valves $576 12 payments
  4. WATCHMAN FLX $552 17 payments
  5. SAPIEN 3 Ultra RESILIA $352 9 payments
  6. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Transcatheter Heart Valves $264 7 payments
  7. WATCHMAN Access System $259 9 payments
  8. Edwards SAPIEN 3 Transcatheter Heart Valve $127 1 payment
  9. ENROUTE Transcarotid Stent $120 1 payment
  10. ENHANCE Transcarotid Peripheral Access Kit $120 1 payment
  11. Other $831 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$56,968

Medicare's payments for the services billed

Medicare patients

223

Average age 76

Services billed

485

101 women, 122 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 54%
Arthritis 44%
Ischemic heart disease 39%
Heart failure 35%
Chronic kidney disease 32%
Diabetes 27%
COPD 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record